Literature DB >> 20488747

A 12-year molecular survey of clinical herpes simplex virus type 2 isolates demonstrates the circulation of clade A and B strains in Germany.

Jonas Schmidt-Chanasit1, Alexandra Bialonski, Patrick Heinemann, Rainer G Ulrich, Stephan Günther, Holger F Rabenau, Hans Wilhelm Doerr.   

Abstract

BACKGROUND: Recently two different herpes simplex virus type 2 (HSV-2) clades (A and B) were described on DNA sequence data of the glycoprotein E (gE), G (gG) and I (gI) genes.
OBJECTIVE: To type the circulating HSV-2 wild-type strains in Germany by a novel approach and to monitor potential changes in the molecular epidemiology between 1997 and 2008. STUDY
DESIGN: A total of 64 clinical HSV-2 isolates were analyzed by a novel approach using the DNA sequences of the complete open reading frames of glycoprotein B (gB) and gG. Recombination analysis of the gB and gG gene sequences was performed to reveal intragenic recombinants.
RESULTS: Based on the phylogenetic analysis of the gB coding DNA sequence 8 of 64 (12%) isolates were classified as clade A strains and 56 of 64 (88%) isolates were classified as clade B strains. Analysis of the gG coding DNA sequence classified 4 (6%) isolates as clade A strains and 60 (94%) isolates as clade B strains. In comparison, the 8 isolates classified as clade A strains using the gB sequence data were classified as clade B strains when using the gG coding DNA sequence, suggesting intergenic recombination events. Intragenic recombination events were not detected.
CONCLUSION: The first molecular survey of clinical HSV-2 isolates from Germany demonstrated the circulation of clade A and B strains and of intergenic recombinants over a period of 12 years. Copyright (c) 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20488747     DOI: 10.1016/j.jcv.2010.04.009

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  4 in total

Review 1.  Vaccination against infectious diseases: what is promising?

Authors:  Hans Wilhelm Doerr; Annemarie Berger
Journal:  Med Microbiol Immunol       Date:  2014-07-27       Impact factor: 3.402

2.  Global Diversity within and between Human Herpesvirus 1 and 2 Glycoproteins.

Authors:  Susanna L Lamers; Ruchi M Newman; Oliver Laeyendecker; Aaron A R Tobian; Robert C Colgrove; Stuart C Ray; David M Koelle; Jeffrey Cohen; David M Knipe; Thomas C Quinn
Journal:  J Virol       Date:  2015-05-27       Impact factor: 5.103

3.  Stability of glycoprotein gene sequences of herpes simplex virus type 2 from primary to recurrent human infection, and diversity of the sequences among patients attending an STD clinic.

Authors:  Lars Haarr; Arvid Nilsen; Per M Knappskog; Nina Langeland
Journal:  BMC Infect Dis       Date:  2014-02-06       Impact factor: 3.090

4.  Novel variants of human herpesvirus 2 from Brazilian HIV-1 coinfected subjects.

Authors:  Lyana Rodrigues Pinto Lima; Nathália Alves de Araújo; Alexandro Guterres; José Henrique Pilotto; Christian Niel; Vanessa Salete de Paula
Journal:  Mem Inst Oswaldo Cruz       Date:  2018-12-03       Impact factor: 2.743

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.